Aviral Kumar
Aviral Kumar
Prime Minister's Research Fellow, Indian Institute of Technology Guwahati
Verified email at iitg.ac.in
Cited by
Cited by
Vimentin activation in early apoptotic cancer cells errands survival pathways during DNA damage inducer CPT treatment in colon carcinoma model
S Chakraborty, A Kumar, MM Faheem, A Katoch, A Kumar, VL Jamwal, ...
Cell death & disease 10 (6), 1-16, 2019
EMT in breast cancer metastasis: an interplay of microRNAs, signaling pathways and circulating tumor cells
A Kumar, A Golani, LD Kumar
Front. Biosci 25, 979-1010, 2020
Gene therapy as a potential tool for treating neuroblastoma—a focused review
MD Kumar, A Dravid, A Kumar, D Sen
Cancer gene therapy 23 (5), 115-124, 2016
MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
K Rishabh, S Khadilkar, A Kumar, I Kalra, AP Kumar, AB Kunnumakkara
International Journal of Molecular Sciences 22 (5), 2561, 2021
Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases
UD Daimary, D Parama, V Rana, K Banik, A Kumar, C Harsha, ...
Current Research in Pharmacology and Drug Discovery, 100008, 2020
Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2
A Katoch, D Nayak, MM Faheem, A Kumar, PK Sahu, AP Gupta, ...
Cell Death Discovery 7, 25, 2021
From Simple Mouth Cavities to Complex Oral Mucosal Disorders—Curcuminoids as a Promising Therapeutic Approach
S Girisa, A Kumar, V Rana, D Parama, UD Daimary, S Warnakulasuriya, ...
ACS pharmacology & translational science 4 (2), 647-665, 2021
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
KK Thakur, A Kumar, K Banik, E Verma, E Khatoon, C Harsha, G Sethi, ...
Journal of Cellular Physiology, 2021
RNA interference and Nanotechnology: A promising alliance for next generation cancer therapeutics
G Swaminathan, A Shigna, A Kumar, VV Byroju, VR Durgempudi, ...
Frontiers in Nanotechnology 3, 42, 2021
Multitargeting effects of calebin A on malignancy of CRC cells in the multicellular tumor microenvironment
C Buhrmann, AB Kunnumakkara, A Kumar, M Samec, P Kubatka, ...
Frontiers in Oncology 11, 2021
Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases
A Kumar, C Harsha, P Dey, S Girisa, UD Daimary, X Mao, ...
Phytotherapy Research, 2021
Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
E Verma, A Kumar, UD Daimary, D Parama, S Girisa, G Sethi, ...
Journal of Functional Foods 86 (13), 2021
The promising potential of piperlongumine as an emerging therapeutics for cancer
D Parama, V Rana, S Girisa, E Verma, UD Daimary, KK Thakur, A Kumar, ...
Exploration of Targeted Anti-tumor Therapy, 2021
Bioinformatics of MicroRNA Target Prediction
A Rawoof, A Kumar, S Tiwari, LD Kumar
Bioinformatics and Human Genomics Research, 2021
Acute Lymphoblastic Leukemia: Promising Technologies for the Management of the Disease
G Swaminathan, VV Byroju, A Kumar, K Kourani, LD Kumar
Advances in Health and Disease 37, 1-79, 2021
Quantitative proteome profiling stratifies fibroepithelial lesions of the breast
A Kumar, DS Nayakanti, KK Mangalaparthi, V Gopinath, NVN Reddy, ...
Oncotarget 12 (5), 507-518, 2021
Probable Role of Non-exosomal Extracellular Vesicles in Colorectal Cancer Metastasis to Kidney: An In Vitro Cell Line Based Study and Image Analysis
A Kumar, R Nag, S Mishra, B Ramakrishna, VVR Sai, D Mishra
ICTMI 2017, 163-174, 2019
The system can't perform the operation now. Try again later.
Articles 1–17